METHODS FOR TREATING CANCERS WITH CYTOPLASMIC EXPORTIN 7 (XPO7) EXPRESSION WITH TIVOZANIB
Technology
E-028-2022
Patent ID
E-028-2022-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
63/283,406
IC
NCI
Date Filed
Date Issued
Patent PDF